Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Decompensated Heart Failure
39%
Aortic Stenosis
58%
Aortic Valve
37%
Aortic Valve Replacement
33%
Apoplexy
94%
Arterial Stiffness
90%
Atrial Fibrillation
92%
Bicuspid Aortic Valve
65%
Blood Pressure
94%
Cardiac Computed Tomography
37%
Cardiac Magnetic Resonance Imaging
43%
Cardiovascular Risk
36%
Cardiovascular System
62%
Carotid Artery
49%
Cohort Analysis
57%
Common Carotid Artery
51%
Computer Assisted Tomography
100%
Congestive Heart Failure
50%
Coronary Artery Calcium
46%
Coronary Artery Disease
92%
Diabetes
73%
Diabetes Mellitus
68%
Diastolic Dysfunction
41%
Diastolic Function
33%
Disease Marker
39%
Echocardiography
79%
Elderly Patient
34%
Hazard Ratio
65%
Hemodynamic
45%
High Risk Population
44%
Hypertension
56%
Isotopes of Calcium
47%
Left Atrial Volume
82%
Left Ventricle
39%
Left Ventricular Hypertrophy
60%
Metabolic Syndrome
48%
Mitral Insufficiency
63%
Mitral Valve
33%
Mitral Valve Replacement
58%
Mitral Valve Stenosis
89%
Mitral Valve Surgery
52%
Odds Ratio
77%
Patient with Hypertension
56%
Prevalence
66%
Pulmonary Hypertension
39%
Systolic Blood Pressure
70%
Systolic Function
49%
Thrombus
50%
Transthoracic Echocardiography
97%
Valvular Heart Disease
43%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
18%
Acute Heart Failure
15%
All Cause Mortality
26%
Angiotensin Receptor Antagonist
22%
Antihypertensive Agent
8%
Aortic Arch Syndrome
7%
Aortic Regurgitation
7%
Atorvastatin
15%
Atrial Fibrillation
23%
Bacterial Endocarditis
15%
Cardiovascular Mortality
36%
Cardiovascular Risk
11%
Cerebrovascular Accident
39%
Chronic Kidney Failure
8%
Cohort Study
50%
Congestive Heart Failure
17%
Coronary Artery Calcification
7%
Coronary Artery Disease
60%
Diabetes Mellitus
48%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Dyslipidemia
23%
Edoxaban
7%
Endothelial Dysfunction
15%
Enkephalinase Inhibitor
7%
Fabry Disease
7%
Fimasartan
7%
Fluorouracil
15%
Glucagon Like Peptide 1 Receptor Agonist
7%
Heart Infarction
20%
Heart Left Ventricle Hypertrophy
22%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
18%
Hypertension
55%
Hypertrophic Cardiomyopathy
15%
Infarction
15%
Lipid
10%
Malignant Neoplasm
23%
Marfan Syndrome
7%
Metabolic Syndrome X
23%
Mitral Valve Stenosis
15%
Placebo
15%
Prematurity
15%
Prevalence
31%
Randomized Clinical Trial
7%
Rosuvastatin
23%
ST Segment Elevation Myocardial Infarction
15%
Statin (Protein)
17%
Thrombus
7%
Triflusal
15%
Warfarin
7%
Wernicke's Encephalopathy
15%
Nursing and Health Professions
Acute Heart Failure
15%
All Cause Mortality
12%
Angiotensin Receptor
7%
Aortic Aneurysm
17%
Aortic Regurgitation
15%
Blood Pressure
37%
Blood Pressure Measurement
11%
Body Mass
11%
Cardiac Resynchronization Therapy
7%
Cardiovascular Magnetic Resonance
23%
Cardiovascular Mortality
15%
Cardiovascular System
27%
Cerebrovascular Accident
11%
Color Doppler Echocardiography
20%
Color Doppler Flowmetry
7%
Computed Tomographic Angiography
14%
Computer Assisted Tomography
25%
Confidence Interval
23%
Coronary Artery Calcium Score
22%
Coronary Artery Disease
44%
D Dimer
7%
Diabetes Mellitus
25%
Dual Energy Computed Tomography
15%
Dyslipidemia
13%
Elderly Patient
15%
Enkephalinase Inhibitor
7%
Exercise Electrocardiography
7%
Gender Difference
7%
Glucose
8%
Heart Infarction
17%
Heart Left Ventricle Endsystolic Volume
7%
High Risk Population
25%
Hypertension
32%
Insulin Resistance
15%
Mitral Valve Regurgitation
8%
Nuclear Magnetic Resonance Imaging
15%
Odds Ratio
31%
Patient with Hypertension
8%
Patient with Type 2 Diabetes
7%
Predictive Value
11%
Prevalence
39%
Prognostication
7%
Proportional Hazards Model
10%
Pulse Pressure
7%
Surface Area
20%
Target Organ
7%
Transthoracic Echocardiography
14%
Triacylglycerol
15%
Venous Thromboembolism
7%
Warfarin
7%
